Evidence map›Paper›PMID 27617301›Full record

ArticleJournal of reward deficiency syndrome

Designer Drugs: A Synthetic Catastrophe.

James Fratantonio, Lawrence Andrade, Marcelo Febo

Open access · diamondAbstract read
In one paragraph

Article in Journal of reward deficiency syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Reply to "MDPV-induced aggression in humans not established".International journal of legal medicine · 2020
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

James FratantonioDivision of Applied Clinical Research, Dominion Diagnostics, LLC, North Kingstown, RI, USA.
Lawrence AndradeDivision of Research and Development, Dominion Diagnostics, LLC, North Kingstown, RI, USA.
Marcelo FeboDepartment of Psychiatry and McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA.
Dominion Diagnostics (United States) · US

Funding

Imaging In Vivo Neural Mechanisms of Synthetic Cathinones (Bath Salts)R21DA038009 · NIDA · UNIVERSITY OF FLORIDA · PI FEBO, MARCELO · 2015 to 2016
$411k
NIDA NIH HHS R21 DA038009
6 · The paper itself

Abstract

Synthetic stimulants can cause hallucinations, aggressive behaviors, death and are sometimes legal. These substances are sold as plant food and bath salts that are "Not for Human Consumption", therefore skirting the 1986 Federal Analogue Act and giving a false pretense of safety. Studies have proved that these substances are toxic, have a high abuse potential, and are becoming extremely prevalent in the United States. This creates a dilemma for law enforcement agents, hospitals, and substance use disorder treatment centers. Urine Drug Testing is utilized as a clinical diagnostic tool in substance use disorder treatment centers, and the furious pace at which new synthetic stimulants are introduced to the black market are making the detection via urine increasingly difficult. This article will discuss the prevalence, pharmacology and difficulty developing laboratory assays to detect synthetic stimulants.

Indexed as

Bath saltsDesigner drugsMDPVMephedroneMethyloneα-PVP

Identifiers

PMID27617301
PMCPMC5013729
OpenAlexW2554370979

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.